Faculty Opinions recommendation of c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont.

Author(s):  
Rick Maizels
Nature ◽  
2019 ◽  
Vol 566 (7744) ◽  
pp. E7-E7
Author(s):  
Mo Xu ◽  
Maria Pokrovskii ◽  
Yi Ding ◽  
Ren Yi ◽  
Christy Au ◽  
...  

2000 ◽  
Vol 2 (9) ◽  
pp. 1-20 ◽  
Author(s):  
Mark Harber ◽  
Anette Sundstedt ◽  
David Wraith

Current immunosuppression protocols, although often effective, are nonspecific and therefore hazardous. Consequently, immunological tolerance that is antigen specific and does not globally depress the patient's immune system has become one of the Holy Grails of immunology. Since the discovery that cytokines have immunomodulatory effects, extensive research has investigated the potential of these molecules to induce and maintain specific immunological tolerance in the context of transplantation, allergy and autoimmunity. In this article, we review the possible mechanisms by which cytokines can modulate the immune response and the animal models that frequently confound the theory that a single cytokine, or group of cytokines, can induce tolerance in a predictable manner. Finally, we discuss the role of cytokines at a paracrine level, particularly in the context of inducing and maintaining antigen-specific, regulatory T cells with the clinical potential to suppress specific immune responses.


2021 ◽  
Vol 10 (24) ◽  
pp. 5907
Author(s):  
Toru Tanaka ◽  
Naoto Sasaki ◽  
Yoshiyuki Rikitake

Atherosclerotic diseases, including ischemic heart disease and stroke, are a main cause of mortality worldwide. Chronic vascular inflammation via immune dysregulation is critically involved in the pathogenesis of atherosclerosis. Accumulating evidence suggests that regulatory T cells (Tregs), responsible for maintaining immunological tolerance and suppressing excessive immune responses, play an important role in preventing the development and progression of atherosclerosis through the regulation of pathogenic immunoinflammatory responses. Several strategies to prevent and treat atherosclerosis through the promotion of regulatory immune responses have been developed, and could be clinically applied for the treatment of atherosclerotic cardiovascular disease. In this review, we summarize recent advances in our understanding of the protective role of Tregs in atherosclerosis and discuss attractive approaches to treat atherosclerotic disease by augmenting regulatory immune responses.


Nature ◽  
2018 ◽  
Vol 554 (7692) ◽  
pp. 373-377 ◽  
Author(s):  
Mo Xu ◽  
Maria Pokrovskii ◽  
Yi Ding ◽  
Ren Yi ◽  
Christy Au ◽  
...  

2021 ◽  
Author(s):  
Liliana Moura Massis ◽  
Sarah Ruddle ◽  
Susan M Brewer ◽  
Ruth Schade ◽  
Ramya Narasimhan ◽  
...  

Superspreader hosts carry out most pathogen transmission events and are often disease tolerant since they remain asymptomatic despite high pathogen burdens.  Here we describe the superspreader immune state that allows for disease tolerance. In a model of Salmonella infection, superspreader mice develop colitis with robust CD4 + and CD8 + T-cell responses, however, they remain asymptomatic. We found that superspreaders have significantly more regulatory T cells (Tregs) in the distal gut compared to non-superspreader infected hosts. Surprisingly, the depletion of Tregs did not induce pathogen clearance but rather exacerbated weight loss, increased gut inflammation, and compromised epithelial intestinal barrier. This loss of tolerance correlated with dramatic increases in cytotoxic CD4 + and CD8 + T cells. Interestingly, CD4 neutralization in Tregs-depleted superspreaders was sufficient to rescue tolerance. Our results indicate that Tregs play a crucial role in maintaining immunologic tolerance in the guts of superspreader mice by suppressing cytotoxic CD4 + and CD8 + T-cell activities.


Immunotherapy ◽  
2009 ◽  
Vol 1 (4) ◽  
pp. 631-644
Author(s):  
Carolin Daniel ◽  
Jens Nolting ◽  
Harald von Boehmer

This review discusses different mechanisms that result in immunological tolerance, such as intrathymic deletion of immature T cells, intrathymic and extrathymic generation of regulatory T cells, effector mechanisms of regulatory T cells as well as molecular pathways involved in extrathymic generation of regulatory T cells in vivo and in vitro. These molecular mechanisms should enable investigators to develop clinical protocols aiming at the specific prevention of unwanted immune responses, thereby replacing indiscriminate immunosuppression that often has fatal consequences.


Sign in / Sign up

Export Citation Format

Share Document